9PT Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Pliant Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.979 EUR -2.05% Market Closed

Market Cap: €58.6m

P	Pliant Therapeutics Inc F:9PT	US
N	Nov Inc SWB:NO8	US
J	Jiangsu Expressway Co Ltd F:JE2	CN
L	Lowe's Companies Inc DUS:LWE	US
L	Lowe's Companies Inc F:LWE	US
P	PriceSmart Inc F:PS8	US
	Banco Bilbao Vizcaya Argentaria SA F:BBVA	ES
	Kemper Corp NYSE:KMPR	US
M	Moderna Inc F:0QF	US
C	CubeSmart F:UK8	US
U	Ulta Beauty Inc F:34U	US
A	Addus Homecare Corp F:A41	US
I	Infineon Technologies AG XMUN:IFX	DE
W	Weyerhaeuser Co SWB:WHC	US
W	Western Alliance Bancorp XBER:WEA	US
	Dexus F:0DPS	AU

Profitability Summary

Pliant Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Low Operating Margin

Negative 3Y Average Operating Margin

-24 377%

Low Net Margin

Negative 3Y Average Net Margin

-21 439%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-15 115%

Negative ROE

-68%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-881%

ROIC is Increasing

-847% > -544%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.